StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)

Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –

biote operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

biote's operating cash flow for the twelve months ending Jun 30, 2026 was $24.37M, down 41.3% year over year. For fiscal 2025 it was $35.19M, down 22.2% from the year before. The highest annual figure on record is $45.24M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$35.19M-22.2%
FY2024Dec 31, 2024$45.24M+68.3%
FY2023Dec 31, 2023$26.88M–
FY2022Dec 31, 2022-$9.16M-127.2%
FY2021Dec 31, 2021$33.72M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.18M-116.6%
Q1 FY2026Mar 31, 2026$3.90M-39.7%
Q4 FY2025Dec 31, 2025$7.57M-38.8%
Q3 FY2025Sep 30, 2025$14.07M-9.5%
Q2 FY2025Jun 30, 2025$7.09M-28.8%
Q1 FY2025Mar 31, 2025$6.47M-12.3%
Q4 FY2024Dec 31, 2024$12.37M+77.8%
Q3 FY2024Sep 30, 2024$15.56M+9622.5%
Q2 FY2024Jun 30, 2024$9.95M+46.8%
Q1 FY2024Mar 31, 2024$7.37M-43.3%
Q4 FY2023Dec 31, 2023$6.96M+15.0%
Q3 FY2023Sep 30, 2023$160.00K-97.5%
Q2 FY2023Jun 30, 2023$6.78M–
Q1 FY2023Mar 31, 2023$12.99M+86.4%
Q4 FY2022Dec 31, 2022$6.05M-40.0%
Q3 FY2022Sep 30, 2022$6.39M+1.1%
Q2 FY2022Jun 30, 2022-$28.57M-259.2%
Q1 FY2022Mar 31, 2022$6.97M–
Q4 FY2021Dec 31, 2021$10.08M–
Q3 FY2021Sep 30, 2021$6.32M–
Q2 FY2021Jun 30, 2021$17.94M–
Q1 FY2021Mar 31, 2021-$627.00K–
Q3 FY2020Sep 30, 2020$0–

More biote figures

See a number that looks wrong?